[1] |
CAO Ailing, CAO Zhe, ZHOU Jian.
Effects of docetaxel combined with thymosin α1 on number of Treg in immune microenvironment of rats with breast cancer and its mechanism
[J]. China Oncology, 2021, 31(9): 799-806.
|
[2] |
Onco-endocrinology Society of Chinese Anti-Cancer Association, Onco-endocrinology Committee of Chongqing Association of Integrative Medicine.
Guidelines for the management of tumor-associated hyperglycemia (2021 edition)
[J]. China Oncology, 2021, 31(7): 651-688.
|
[3] |
NIU Na, LIN Yansong.
Application and research progress of selective internal radiation therapy with 90 Y microspheres in hepatocellular carcinoma
[J]. China Oncology, 2021, 31(5): 428-434.
|
[4] |
ZHU Junjun, GE Naijian, YANG Yefa.
Current status and prospects of migration of radioactive 125 I seed implanted in malignant tumor
[J]. China Oncology, 2021, 31(4): 257-262.
|
[5] |
QIAO Tingting , GE Shujing , LUO Yuan , LU Chengrong , DUAN Lianning .
Mechanism of inhibition of epithelial-to-mesenchymal transition by phosphorylated H2AX in lung cancer cells
[J]. China Oncology, 2021, 31(4): 277-284.
|
[6] |
MU Lina , SU Jia , YU Shunzhang , NIU Rungui , HAN Xiaoyou , LIU Li , SHI Jianping , ZHANG Zuofeng .
The control of lung cancer relating to quitting active smoking and secondary smoking: a case-control study of lung cancer in Taiyuan
[J]. China Oncology, 2021, 31(4): 335-343.
|
[7] |
ZHAO Yuanyuan , ZHOU Jianying , FAN Yun , WANG Jialei , HUANG Dingzhi , LI Junling , SHI Meiqi , LIU Jiwei , YAO Yu , WU Lin , YAO Wenxiu , ZHANG Li .
Advances in the treatment of BRAF V600-mutant non-small cell lung cancer
[J]. China Oncology, 2021, 31(12): 1145-1152.
|
[8] |
SHI Wanhong , ZOU Lei , KANG Qiang , WANG Junfeng , BAI Jianhua , JIN Yun , ZHANG Jie , ZHANG Xiaowen .
The influence of silencing leptin gene on the invasion and migration abilities of gallbladder cancer GBC-SD and OCUG cells
[J]. China Oncology, 2021, 31(11): 1050-1057.
|
[9] |
PAN Jian, WEI Yu, YE Dingwei, ZHU Yao.
Correlation between EGFR (rs884419) gene polymorphism and clinicopathological characteristics of prostate cancer
[J]. China Oncology, 2021, 31(11): 1104-1109.
|
[10] |
WU Chunxiao , GU Kai , PANG Yi , BAO Pingping , WANG Chunfang , SHI Liang , GONG Yangming , XIANG Yongmei , DOU Jianming , SHI Yan , FU Chen .
Analysis of the current status of cancer incidence and mortality in Shanghai, 2016 and trends of 2002-2016
[J]. China Oncology, 2021, 31(10): 879-891.
|
[11] |
LIU Jiawei, LI Dan, ZHAI Qing.
Risk factors analysis of liver injury induced by chemotherapy in patients with breast cancer
[J]. China Oncology, 2021, 31(1): 52-62.
|
[12] |
WANG Xiaodong , ZHOU Dandan , ZHANG Liping , ZHENG Quan , MU Qingjie , YIN Chonggao , LI Hongli .
FAM83A is highly expressed in lung adenocarcinoma tissues and promotes invasion and metastasis of lung adenocarcinoma cells
[J]. China Oncology, 2020, 30(8): 586-592.
|
[13] |
TIAN Wen , CHEN Long , MA Yanhua , WU Kaili , FU Guohong .
Expressions of serum miR-135 and miR-601 and their diagnostic value in patients with gastric cancer
[J]. China Oncology, 2020, 30(8): 593-598.
|
[14] |
YANG Xiaoling, SI Lu, MAO Lili, WANG Xuan, CUI Chuanliang, CHI Zhihong, SHENG Xi’nan, GUO Jun.
Adverse events of pembrolizumab in patients with advanced melanoma and correlation analysis
[J]. China Oncology, 2020, 30(5): 362-368.
|
[15] |
XIE Tiansong , MA Xiaoxi , TONG Tong , ZHOU Zhengrong .
Evaluating hyaluronan content of pancreatic cancer based on CT texture analysis
[J]. China Oncology, 2020, 30(3): 224-230.
|